ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,447,153, issued on Oct. 21, was assigned to Pfizer Inc. (New York).
"HER2 mutation inhibitors" was invented by Bryan Daniel Ellis (Denver), Erik James Hicken (Longmont, Colo.), Ellen Ruth Laird (Longmont, Colo.), Nicholas Charles Lazzara (Denver), Bradley Jon Newhouse (Broomfield, Colo.), Spencer Phillip Pajk (Boulder, Colo.), Rachel Zoe Rosen (Broomfield, Colo.) and Russell Andrew Shelp (Boulder, Colo.).
According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to compounds of Formula (I):and enantiomers thereof, and to pharmaceutically acceptable salts of Formula (I) and said enantiomers, wherein A, L2, R1, R2, R3, R4, and n are as defined h...